Advertisement

Topics

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2018: Updated Deal Trends, Players and Financials – ResearchAndMarkets.com

14:04 EST 27 Nov 2018 | Biotech 365

DUBLIN–(BUSINESS WIRE)–The “Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Monoclonal Antibody Partnering 2012-2018: Deal trends, players, financials and forecasts report provides an understanding … Continue reading

Original Article: Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2018: Updated Deal Trends, Players and Financials – ResearchAndMarkets.com

NEXT ARTICLE

More From BioPortfolio on "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2018: Updated Deal Trends, Players and Financials – ResearchAndMarkets.com"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...